Thomas Goetz

And none of these have been large-scale randomized control trials in humans.

So the data is scant, despite what Mel Gibson says.

But what has changed is who was in charge back in Washington.

And in February, 2026, the new director of the National Institutes of Health, who has said the NIH should serve as the research arm of Maha.

And the head of the National Cancer Institute said that they had funded studies of ivermectin cancer treatments that are already underway.

Here's what the head of the NIH said.

If lots of people believe it and it's moving public health, we at NIH have an obligation, again, to treat it seriously.

Well, that's not actually the way it's supposed to work.

Just because people believe something does not mean it's worthy of study or that it is worth the money, our money, to do the research.

But whatever.

That's the way they make decisions now.

Studies are underway.

Maybe it works.

Who knows?

And the great state of Florida isn't far behind.

In late 2025, the Surgeon General of the Sunshine State announced a $60 million cancer innovation fund that would study, among other things, the value of ivermectin for cancer treatments.

This is fine.

It's what I have argued for in this show, after all.

Do the science.

Test your hypotheses.